NPPA Revises Cancer Drug Prices, Some Unchanged

• NPPA issued a revised price list for 643 cancer drug packs, with an average price cut of 38.22%.
• Nearly 25% of cancer drug packs saw no price reduction, including some costing several lakh rupees.
• The new prices are effective from November 9, as per the NPPA release.
• Health experts argue that controlling trade margins alone is insufficient for making cancer treatment affordable.
• JSA India emphasizes that life-saving cancer treatment must be affordable based on medical need, not a patient’s ability to pay.